PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 5/29
Copy link
Facebook
Email
Notes
More

Market Analysis and Trades for 5/29

PharmD_KS's avatar
PharmD_KS
May 28, 2025
∙ Paid
11

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 5/29
Copy link
Facebook
Email
Notes
More
2
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so there is no reason to subscribe to both.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

SPY 0.00%↑

QQQ 0.00%↑ had a look above and fail of the top of its range at open which led to some weakness into NVDA 0.00%↑ ER.

The top of this box corresponds to the 21520-21560 range on NQ. The sell into the NVDA 0.00%↑ release came into the weekly 21320-21340 spot with the low on the release at 321.25. NQ became key today as it was at the top of its range. An upside breakout on NQ/QQQ likely leads an ES/SPY upside breakout. If this sustains as a failed breakout we can see some continued weakness. Thus far the NVDA results have been well received and NQ is coming back into the 520-560 range.

We played the short side early on the failed breakout, then later flipped to look for longs.

Price is still making higher daily highs and higher lows. Until/unless we start seeing traction below a prior day low, that won’t change.

Paid Content Below or in the Discord

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More